Inspire Medical Systems Inc. (INSP)
NYSE: INSPHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
INSP stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.60B
- P/E (TTM)
- 16.45
- Forward P/E
- 36.85
- EPS (TTM)
- $3.35
- Dividend yield
- None
- 52-week range
- 38.91 – 147.03
- Day range
- 54.92 – 56.93
- Volume / Avg
- 552.32K / 765.67K
- Beta
- —
- Shares outstanding
- 28.97M
52-week range
INSP stock today
Inspire Medical Systems (INSP) closed at $55.10 on Nov 20, down 2.10% (-$1.18), versus the S&P 500's 3.70% decline. At this level, INSP sits near the bottom of its 52-week range of $38.91 to $147.03: 62.5% below the high, set on Dec 10, 2025 and 41.6% above the low. INSP is down 40.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 38.7%.
Inspire Medical Systems trades at 16.4x its trailing twelve-month earnings per share of $3.35. Its forward P/E of 36.8x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Inspire Medical Systems
Company profileInspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Timothy P. Herbert
- Headquarters
- Golden Valley, MN
- Employees
- 1,333
- IPO year
- 2018
- Website
- inspiresleep.com
Financial highlights
Full financialsIn fiscal 2025, Inspire Medical Systems generated $912.0 million in revenue, up 13.6% from fiscal 2024, its 8th consecutive year of revenue growth. Net income was $145.4 million (+171.8% year over year), for a net margin of 15.9% versus a median of -11.0% in the prior 5 years. Gross margin was 85.4% (up from 84.7%) and operating margin 5.6%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $911.98M | $802.80M | $624.80M | $407.86M | $233.39M |
| Growth | +13.60% | +28.49% | +53.19% | +74.75% | +102.28% |
| Net income | $145.42M | $53.51M | $-21.15M | $-44.88M | $-42.04M |
| EPS (diluted) | $4.89 | $1.75 | $-0.72 | $-1.60 | $-1.54 |
Analyst forecast
ForecastConsensus (18 analysts)
hold
Avg. price target
$69.38+25.92%
- Strong buy 0
- Buy 4
- Hold 11
- Sell 1
- Strong sell 2
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 2, 2026
- EPS actual vs est.
- $-0.84 vs $0.10
- Surprise
- -940.00%
INSP news
All INSP news- Nyxoah SA Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court Case Regarding European Patent 2 760 534Nasdaq
- Nyxoah obtains default judgment in patent infringement case against Inspire Medical SystemsSeeking Alpha
- Nyxoah Obtient une Décision par Défaut contre Inspire Medical Systems dans une Procédure devant l’Unified Patent CourtGlobeNewswireNYXH, INSP
- Nyxoah Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court CaseGlobeNewswireNYXH, INSP
- Inspire Medical Systems, Inc. to Present at the Piper Sandler 38th Annual Healthcare ConferenceGlobeNewswire
- Here's Why You Should Retain INSP Stock in Your Portfolio for NowNasdaqINSP, ISRG, WST, GKOS
- INSP Is Up 12.1% in Three Months: Can Its Rally Continue From Here?NasdaqINSP, RMD, NYXH
- Inspire Turns Q3 Loss Of $24 Mln With Higher Expenses; Narrows Revenue Guidance For 2026NasdaqINSP, HEI.A
Inspire Medical Systems peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XRAYDENTSPLY SIRONA Inc. | 8.29 | -2.36% | $1.65B | vs INSP |
| LMATLeMaitre Vascular Inc. | 73.61 | -1.67% | $1.68B | vs INSP |
| KMTSKestra Medical Technologies Ltd. | 25.10 | -5.75% | $1.50B | vs INSP |
| PRCTPROCEPT BioRobotics Corporation | 24.70 | -4.08% | $1.42B | vs INSP |
| NVCRNovoCure Limited | 10.71 | +0.19% | $1.25B | vs INSP |
| TNDMTandem Diabetes Care Inc. | 17.46 | +3.93% | $1.22B | vs INSP |
| DRTSAlpha Tau Medical Ltd. | 11.76 | +3.93% | $1.09B | vs INSP |
| SIBNSI-BONE Inc. | 23.73 | -0.08% | $1.07B | vs INSP |
Indexes, lists and sector
Inspire Medical Systems stock FAQ
What is Inspire Medical Systems's stock price today?
INSP last traded at $55.10 as of Nov 20, 4:00 PM EST, down 2.10% on the day. Prices are delayed at least 15 minutes.
What is INSP's P/E ratio?
INSP trades at a trailing P/E ratio of 16.45 and a forward P/E of 36.85.
Who is Inspire Medical Systems's CEO?
Mr. Timothy P. Herbert is the chief executive officer of Inspire Medical Systems Inc., which has about 1,333 employees.
What is the INSP 52-week high?
The 52-week high for INSP is $147.03 and the 52-week low is $38.91. The stock is currently 62.5% below its high.